Mr. Robert S Liles, BSPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4201 Sunny Meadows Rd, Bartlett, TN 38135 Phone: 901-383-8639 |
Mary Jane Mcdonald, DPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 6697 Stage Rd, Bartlett, TN 38134 Phone: 901-373-6498 Fax: 901-373-3660 |
Megan Rowlett Denbow, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2879 N Germantown Pkwy, Bartlett, TN 38133 Phone: 901-371-9148 |
Katherine Habkouk Pharmacist - Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist Medicare: Not Enrolled in Medicare Practice Location: 7615 Us Highway 70, Bartlett, TN 38133 Phone: 901-758-3626 |
Dr. Joshua Thomas White, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 8480 Us Highway 64, Bartlett, TN 38133 Phone: 901-384-9406 |
Dr. Ashley Altizer, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 6565 Saint Elmo Rd, Bartlett, TN 38135 Phone: 901-383-1547 |
News Archive
A clinical trial for a vaccine to protect against the novel coronavirus commenced this Monday in the U.S.. If successful, this could mean an end to the current global pandemic of COVID-19 infections, feel experts.
According to researchers in the U.S. a mechanism found in some people's brain could be the key to them staying relaxed in stressful situations.
Imaging with the molecular imaging tracer 18F-FDOPA can help distinguish radiation-induced lesions from new tumor growth in patients who have been treated with radiation for brain metastases, according to new research published in The Journal of Nuclear Medicine. Using this amino acid tracer, researchers found that physicians could accurately differentiate the two types of lesions 83 percent of the time. Progression-free survival could also be predicted through evaluating the 18F-FDOPA imaging results.
Diabetes treatment regimens containing AFREZZATM (insulin human [rDNA origin]) Inhalation Powder, a well-tolerated, ultra rapid acting insulin, provide glucose control similar to standard insulin therapy along with weight loss and reduced incidence of hypoglycemia in patients with Type 1 diabetes and poorly controlled blood sugar levels, according to a two-year study presented today at the American Association of Clinical Endocrinologists 19th Annual Meeting (Poster #283).
According to new research findings presented this week at the 2019 ACR/ARP Annual Meeting, there is a profound ongoing need for additional medications to control the signs and symptoms of juvenile idiopathic arthritis, despite the availability of several approved biologic disease-modifying antirheumatic drugs (biologics).
› Verified 1 days ago